Dr. Porter provides state-of-the-art, minimally invasive treatment options to patients with urologic cancer and stone disease to reduce the pain and recovery from surgical treatment. He stays current on the latest available treatments by teaching at national and international urologic meetings as well as publishing his outcomes. Dr. Porter was the 2023 recipient of the Menon Award in Robotic Urologic Surgery. Dr. Porter is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Chromophobe Renal Cell Carcinoma, Familial Wilms Tumor 2, WT1-Related Wilms Tumor Syndromes, Vasectomy, and Reconstructive Urology Surgery.

Dr. Lee feels that open, honest communication is fundamental to the patient-doctor relationship, and strives to partner with her patients in a shared decision-making model of care. Dr. Lee has received both regional and national awards for her research in prostate and kidney cancer outcomes and epidemiology. She completed an advanced robotics fellowship in Seattle, WA. Dr. Lee is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). Her top areas of expertise are Familial Wilms Tumor 2, Renal Cell Carcinoma (RCC), Ureterocele, Reconstructive Urology Surgery, and Nephrectomy.

Dr. Zhao believes in providing the best cancer care through multidisciplinary, evidence-based — yet personalized — approaches. Dr. Zhao is rated as an Advanced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Prostate Cancer, Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, and Familial Prostate Cancer.

Scott Tykodi is an Oncologist in Seattle, Washington. Dr. Tykodi is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, Adult Soft Tissue Sarcoma, and Nephrectomy. Dr. Tykodi is currently accepting new patients.

Dr. Somasundaram Subramaniam is a Medical Oncologist at the Swedish Cancer Institute in Seattle, Washington and a 2021 Seattle Met Top Doctor Award winner. He has specialized expertise in the management of Gastrointestinal (GI) Cancers. This includes common cancers like colon and rectal cancers and also less common cancers like stomach cancer, neuroendocrine tumors (NETs) and liver and bile duct cancers. He also treats patients with lung cancer and kidney cancer. Dr. Soma chose to pursue a career in Oncology to help patients diagnosed with very serious illnesses and their families by providing hope, education and the best opportunities for treatment and cure. He is thrilled to be working with at Swedish, which has an excellent group of caring and highly-trained physicians, nurses and providers who all work very closely together with a robust multi-disciplinary team approach.. Dr. Subramaniam is an investigator on several clinical trials and a key member of the Personalized Medicine Research Program at Swedish, which focuses on the using a tumor’s DNA mutations to target it with newer drugs. The Swedish Cancer Institute prioritizes opening cutting-edge clinical trials to ensure patients have access to the latest innovations in cancer therapy. Dr. Subramaniam graduated from medical school at the National University of Singapore and obtained sub-specialty training during his fellowship at Stanford University, which was supported by a T32 training grant awarded by the National Institutes of Health. He is board-certified in Internal Medicine and Medical Oncology. Dr. Subramaniam also earned a Master of Science degree in Epidemiology and Clinical Research from Stanford. In addition to treating patients with cancer, Dr. Subramaniam is the Medical Director of the Cancer Control program, which emphasizes preventative measures and appropriate cancer screening, to reduce the incidence and burden of cancer in our community. Dr. Subramaniam is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Colorectal Cancer, ALK-Positive Non-Small Cell Lung Cancer, and Nerve Decompression.

Amy Li is a Urologist in Silverdale, Washington. Dr. Li is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). Her top areas of expertise are Urinary Incontinence, Urinary Tract Infection in Children, Renal Cell Carcinoma (RCC), Nephrectomy, and Reconstructive Urology Surgery. Dr. Li is currently accepting new patients.

Samay Jain is a Urologist in Port Orchard, Washington. Dr. Jain is rated as an Advanced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Urinary Tract Infection in Children, Bladder Cancer, Obstructive Uropathy, Nephrectomy, and Reconstructive Urology Surgery. Dr. Jain is currently accepting new patients.

Robert Randolph is a Hematologist Oncology specialist and a Hematologist in Seattle, Washington. Dr. Randolph is rated as an Advanced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Adult Immune Thrombocytopenia, Immune Thrombocytopenic Purpura (ITP), Hemangioma Thrombocytopenia Syndrome, and Pleuropulmonary Blastoma.

Steven Bell is a Radiologist in Bremerton, Washington. Dr. Bell is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Small Cell Lung Cancer (SCLC), WT1-Related Wilms Tumor Syndromes, Colorectal Cancer, and Familial Colorectal Cancer.

Bradley Brown is a Radiologist in Bremerton, Washington. Dr. Brown is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Small Cell Lung Cancer (SCLC), WT1-Related Wilms Tumor Syndromes, Testicular Cancer, and Colorectal Cancer.

James Rohlfing is an Interventional Radiologist in Bremerton, Washington. Dr. Rohlfing is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Small Cell Lung Cancer (SCLC), Chronic Cough, Emphysema, and Familial Colorectal Cancer.

Gary Gretch is a primary care provider, practicing in Internal Medicine in Bremerton, Washington. Dr. Gretch is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Postural Orthostatic Tachycardia Syndrome (POTS), Brugada Syndrome, Short QT Syndrome, and Heart Attack.

As a physician, Dr. Wu strives to provide her patients with not just medical advice, but also emotional, social and spiritual support that is individualized to their needs. She strives to gain her patients trust and provide the best care she can, as she helps them fight illness and preserve dignity. Dr. Wu is rated as an Advanced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). Her top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, Lynch Syndrome, Colorectal Cancer, and Bone Marrow Aspiration.

Jacob Mathew, MD is a fellowship trained, board-certified hematologist/oncologist who believes we are born with essential dignity and his goal is to preserve that dignity, at times using his medical knowledge and at other times just being there for his fellow man. Dr. Mathew believes that the practice of medicine should be evidence-based while simultaneously incorporating the art of medicine. To him, the art of medicine means he needs to be the advocate for his patients. He also hopes to empower his patients to play a pivotal role in their medical care and decision making by teaching them at least the basics of their disease. Dr. Mathew is rated as an Advanced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, Pleuropulmonary Blastoma, Osteotomy, and Bone Marrow Aspiration.

Marc Mitchell is a Urologist in Silverdale, Washington. Dr. Mitchell is rated as an Advanced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Kidney Stones, Reconstructive Urology Surgery, and Nephrectomy. Dr. Mitchell is currently accepting new patients.

Paul Kozlowski, MD, is a board-certified urologist specializing in minimally invasive laparoscopic and robotic surgery for a variety of urologic conditions, including kidney and other urologic cancers, prostate disease and kidney stones (including complex stones). He is experienced with both robotic and radical prostatectomy; renal reconstructive surgery; and ureteropelvic junction obstruction (UPJ). Dr. Kozlowski also offers aquablation treatment for benign prostate hyperplasia (HPB).Dr. Kozlowski strives to put himself in the patient's chair so he can better understand and relieve their concerns and anxieties. He savors his time with his patients and works hard to earn their trust.Dr. Kozlowski is a member of the American Urological Association, Endourological Society and Western Section of the American Urologic Association. He is a Pfizer Scholar in Urology and an associate clinical professor at the University of Washington. Dr. Kozlowski is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Prostate Cancer, Ureterocele, Renal Cell Carcinoma (RCC), Nephrectomy, and Reconstructive Urology Surgery.

John Paul Flores, MD, is a board-certified medical oncologist. He cares for patients with blood disorders and all forms of cancer.Dr. Flores takes the time to guide his patients on their wellness journey, listening to what they say, answering their questions and providing a path forward with hope. In this complex, fast-growing field where new treatments are approved for clinical use regularly, Dr. Flores relies on the expertise of a team of surgeons, pathologists, radiation oncologists and other colleagues to stay at the forefront of cancer treatment and to provide comprehensive, patient-centered care. Dr. Flores is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Prostate Cancer, Muscle Invasive Bladder Cancer, Clear Cell Sarcoma, Prostatectomy, and Splenectomy.

Shailender Bhatia is a Hematologist and an Oncologist in Seattle, Washington. Dr. Bhatia is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Merkel Cell Carcinoma, Melanoma, Neuroendocrine Tumor, and Melanoma of the Eye.

Sasha Joseph is an Oncologist and a Hematologist Oncology provider in Seattle, Washington. Dr. Joseph is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Lung Cancer, Pleuropulmonary Blastoma, and Paget Disease of the Breast. Dr. Joseph is currently accepting new patients.

Sirisha Jain, MD, is a board-certified hematologist/oncologist with Harrison HealthPartners. Dr. Jain's goal is to, in this time of rapid growth of oncology treatments, with new research being published weekly, incorporate the latest treatments into her practice and stay current on the research. She hopes to form a partnership with her patients where she can help them navigate the information and difficult choices a cancer diagnosis brings. Dr. Jain believes it is vital for the health of her patients to focus on treating the whole person and not just the cancer diagnosis. Dr. Jain is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). Her top areas of expertise are Angiosarcoma, Paget Disease of the Breast, Inflammatory Breast Cancer, Myelodysplastic Syndrome (MDS), and Bone Marrow Aspiration.